Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mart Saarma

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Endocrine-Related Cancer|April 24, 2025
Biology of RET receptor and its ligands: focus on the nervous systemArun Kumar Mahato, Mart Saarma
Annals of Medicine|October 16, 2007
Neurotrophic factor receptor RET: structure, cell biology, and inherited diseasesPia Runeberg-Roos, Mart Saarma
Current Opinion in Neurobiology|August 6, 2008
Signalling mechanisms underlying development and maintenance of dopamine neuronsJaan-Olle Andressoo, Mart Saarma
Trends in Pharmacological Sciences|November 17, 2020
Can Growth Factors Cure Parkinson's Disease?Yulia A Sidorova, Mart Saarma
Cell Transplantation|April 6, 2019
CDNF Protein Therapy in Parkinson's DiseaseHenri J Huttunen, Mart Saarma
Nature Reviews. Neuroscience|May 4, 2002
The GDNF family: signalling, biological functions and therapeutic valueMatti S Airaksinen, Mart Saarma
International Journal of Molecular Sciences|September 11, 2020
Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of NeurodegenerationYulia A Sidorova, Mart Saarma
Cell and Tissue Research|September 25, 2020
Editorial for the special issue neurotrophic factorsMart Saarma, William Mobley, Volkmar Leßmann
Neurobiology of Disease|July 19, 2016
Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potentialMaria Lindahl, Mart Saarma, Päivi Lindholm
Human Gene Therapy|July 16, 2015
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene TherapyAndrii Domanskyi, Mart Saarma, Mikko Airavaara
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Endocrine-Related Cancer|April 24, 2025
Biology of RET receptor and its ligands: focus on the nervous systemArun Kumar Mahato, Mart Saarma
Annals of Medicine|October 16, 2007
Neurotrophic factor receptor RET: structure, cell biology, and inherited diseasesPia Runeberg-Roos, Mart Saarma
Current Opinion in Neurobiology|August 6, 2008
Signalling mechanisms underlying development and maintenance of dopamine neuronsJaan-Olle Andressoo, Mart Saarma
Trends in Pharmacological Sciences|November 17, 2020
Can Growth Factors Cure Parkinson's Disease?Yulia A Sidorova, Mart Saarma
Cell Transplantation|April 6, 2019
CDNF Protein Therapy in Parkinson's DiseaseHenri J Huttunen, Mart Saarma
Nature Reviews. Neuroscience|May 4, 2002
The GDNF family: signalling, biological functions and therapeutic valueMatti S Airaksinen, Mart Saarma
International Journal of Molecular Sciences|September 11, 2020
Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of NeurodegenerationYulia A Sidorova, Mart Saarma
Cell and Tissue Research|September 25, 2020
Editorial for the special issue neurotrophic factorsMart Saarma, William Mobley, Volkmar Leßmann
Neurobiology of Disease|July 19, 2016
Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potentialMaria Lindahl, Mart Saarma, Päivi Lindholm
Human Gene Therapy|July 16, 2015
Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene TherapyAndrii Domanskyi, Mart Saarma, Mikko Airavaara
Pageof 16